Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.882 | 0.160 | 6 | 52245936 | upstream gene variant | C/A;T | snv |
|
Respiratory Tract Diseases; Immune System Diseases | 0.030 | 1.000 | 3 | 2011 | 2015 | ||||||||
|
0.827 | 0.120 | 6 | 52240759 | intron variant | G/A;T | snv |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.827 | 0.120 | 6 | 52240759 | intron variant | G/A;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.827 | 0.120 | 6 | 52240759 | intron variant | G/A;T | snv |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.827 | 0.120 | 6 | 52240759 | intron variant | G/A;T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.827 | 0.120 | 6 | 52240759 | intron variant | G/A;T | snv |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.827 | 0.120 | 6 | 52240759 | intron variant | G/A;T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.827 | 0.120 | 6 | 52240759 | intron variant | G/A;T | snv |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.807 | 0.120 | 6 | 52243264 | intron variant | G/A | snv | 0.75 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | < 0.001 | 1 | 2015 | 2015 | |||||||
|
0.807 | 0.120 | 6 | 52243264 | intron variant | G/A | snv | 0.75 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.807 | 0.120 | 6 | 52243264 | intron variant | G/A | snv | 0.75 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.807 | 0.120 | 6 | 52243264 | intron variant | G/A | snv | 0.75 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | < 0.001 | 1 | 2015 | 2015 | |||||||
|
0.807 | 0.120 | 6 | 52243264 | intron variant | G/A | snv | 0.75 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.807 | 0.120 | 6 | 52243264 | intron variant | G/A | snv | 0.75 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | < 0.001 | 1 | 2015 | 2015 | |||||||
|
0.882 | 0.160 | 6 | 52245936 | upstream gene variant | C/A;T | snv |
|
Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.882 | 0.160 | 6 | 52245936 | upstream gene variant | C/A;T | snv |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
1.000 | 0.040 | 6 | 52238749 | missense variant | T/A;G | snv |
|
Stomatognathic Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.925 | 0.080 | 6 | 52240869 | intron variant | G/A;T | snv |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.925 | 0.080 | 6 | 52240869 | intron variant | G/A;T | snv |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.925 | 0.240 | 6 | 52246993 | non coding transcript exon variant | C/A;T | snv |
|
Eye Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.925 | 0.240 | 6 | 52246993 | non coding transcript exon variant | C/A;T | snv |
|
Pathological Conditions, Signs and Symptoms; Immune System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases | 0.010 | < 0.001 | 1 | 2016 | 2016 | ||||||||
|
0.925 | 0.240 | 6 | 52246993 | non coding transcript exon variant | C/A;T | snv |
|
Eye Diseases; Immune System Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
1.000 | 6 | 52237139 | missense variant | G/A | snv | 4.4E-05 | 5.6E-05 |
|
0.800 | 0 | |||||||||||
|
0.925 | 0.120 | 6 | 52236960 | missense variant | C/T | snv | 3.0E-02 | 3.0E-02 |
|
Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
|
0.925 | 0.120 | 6 | 52236960 | missense variant | C/T | snv | 3.0E-02 | 3.0E-02 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 |